Skip to main content
Premium Trial:

Request an Annual Quote

Assay Designs Acquires Stressgen Bioreagents

NEW YORK, July 12 (GenomeWeb News) - Assay Designs said today that it has acquired Stressgen Bioreagents for an undisclosed amount.


Assay Designs will take on Stressgen's employees, bringing the company's total number of workers to 85, Russell Hart, Assay Designs' co-founder and president said in a statement.


Based in Victoria, British Columbia, Stressgen markets develops and markets antibodies, proteins, and related kits to life sciences researchers. Ann Arbor, Mich.-based Assay Designs develops and manufactures immunoassay kits, luminescent reagents, antibodies, and proteins for the life sciences market.

The Scan

Purnell Choppin Dies

Purnell Choppin, a virologist who led the Howard Hughes Medical Institute, has died at 91, according to the Washington Post.

Effectiveness May Decline, Data From Israel Suggests

The New York Times reports that new Israeli data suggests a decline in Pfizer-BioNTech SARS-CoV-2 vaccine effectiveness against Delta variant infection, though protection against severe disease remains high.

To See Future Risk

Slate looks into the use of polygenic risk scores in embryo screening.

PLOS Papers on Methicillin-Resistant Staphylococcus, Bone Marrow Smear Sequencing, More

In PLOS this week: genomic analysis of methicillin-resistant Staphylococcus pseudintermedius, archived bone marrow sequencing, and more.